Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis

Oral mucositis (OM) is the most common disease of the oral mucosa, which affects people’s daily production and life. Triamcinolone ointment is the common clinical drug for OM treatment. However, the hydrophobic properties of triamcinolone acetonide (TA) and the complex microenvironment of the oral c...

Full description

Bibliographic Details
Main Authors: Xiaoying Qu, Xiaoli Guo, Tingting Zhu, Zhe Zhang, Wanchun Wang, Yuanping Hao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2023.1203709/full
_version_ 1797833035114086400
author Xiaoying Qu
Xiaoli Guo
Tingting Zhu
Zhe Zhang
Wanchun Wang
Yuanping Hao
author_facet Xiaoying Qu
Xiaoli Guo
Tingting Zhu
Zhe Zhang
Wanchun Wang
Yuanping Hao
author_sort Xiaoying Qu
collection DOAJ
description Oral mucositis (OM) is the most common disease of the oral mucosa, which affects people’s daily production and life. Triamcinolone ointment is the common clinical drug for OM treatment. However, the hydrophobic properties of triamcinolone acetonide (TA) and the complex microenvironment of the oral cavity led to its low bioavailability and unstable therapeutic effects on ulcer wounds. Herein, dissolving microneedle patches (MNs) composed of mesoporous polydopamine nanoparticles (MPDA) loaded with TA (TA@MPDA), sodium hyaluronic acid (HA), and Bletilla striata polysaccharide (BSP) are prepared as the transmucosal delivery system. The prepared TA@MPDA-HA/BSP MNs exhibit well-arranged microarrays, high mechanical strength and fast solubility (<3 min) properties. In addition, the hybrid structure improves the biocompatibility of TA@MPDA and expedites oral ulcer healing in the SD rat model through the synergistic anti-inflammatory and pro-healing effects of microneedle ingredients (hormones, MPDA and Chinese herbs extracts), with 90% less amount of TA compared with Ning Zhi Zhu®. TA@MPDA-HA/BSP MNs are shown to be their great potential as novel ulcer dressings for OM management.
first_indexed 2024-04-09T14:18:22Z
format Article
id doaj.art-49fbd50d83e640ea9b885d76c8c8d19a
institution Directory Open Access Journal
issn 2296-4185
language English
last_indexed 2024-04-09T14:18:22Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Bioengineering and Biotechnology
spelling doaj.art-49fbd50d83e640ea9b885d76c8c8d19a2023-05-05T05:43:01ZengFrontiers Media S.A.Frontiers in Bioengineering and Biotechnology2296-41852023-05-011110.3389/fbioe.2023.12037091203709Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositisXiaoying Qu0Xiaoli Guo1Tingting Zhu2Zhe Zhang3Wanchun Wang4Yuanping Hao5Department of Stomatology, School of Stomatology of Weifang Medical University, Weifang, ChinaSchool of Stomatology of Qingdao University, Qingdao, ChinaSchool of Stomatology of Qingdao University, Qingdao, ChinaSchool of Stomatology of Qingdao University, Qingdao, ChinaQingdao Stomatological Hospital, Qingdao, ChinaQingdao Stomatological Hospital, Qingdao, ChinaOral mucositis (OM) is the most common disease of the oral mucosa, which affects people’s daily production and life. Triamcinolone ointment is the common clinical drug for OM treatment. However, the hydrophobic properties of triamcinolone acetonide (TA) and the complex microenvironment of the oral cavity led to its low bioavailability and unstable therapeutic effects on ulcer wounds. Herein, dissolving microneedle patches (MNs) composed of mesoporous polydopamine nanoparticles (MPDA) loaded with TA (TA@MPDA), sodium hyaluronic acid (HA), and Bletilla striata polysaccharide (BSP) are prepared as the transmucosal delivery system. The prepared TA@MPDA-HA/BSP MNs exhibit well-arranged microarrays, high mechanical strength and fast solubility (<3 min) properties. In addition, the hybrid structure improves the biocompatibility of TA@MPDA and expedites oral ulcer healing in the SD rat model through the synergistic anti-inflammatory and pro-healing effects of microneedle ingredients (hormones, MPDA and Chinese herbs extracts), with 90% less amount of TA compared with Ning Zhi Zhu®. TA@MPDA-HA/BSP MNs are shown to be their great potential as novel ulcer dressings for OM management.https://www.frontiersin.org/articles/10.3389/fbioe.2023.1203709/fulloral mucositisdissolving microneedlemesoporous polydopamine nanoparticlestriamcinolone acetonideoral ulcer
spellingShingle Xiaoying Qu
Xiaoli Guo
Tingting Zhu
Zhe Zhang
Wanchun Wang
Yuanping Hao
Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
Frontiers in Bioengineering and Biotechnology
oral mucositis
dissolving microneedle
mesoporous polydopamine nanoparticles
triamcinolone acetonide
oral ulcer
title Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
title_full Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
title_fullStr Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
title_full_unstemmed Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
title_short Microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
title_sort microneedle patches containing mesoporous polydopamine nanoparticles loaded with triamcinolone acetonide for the treatment of oral mucositis
topic oral mucositis
dissolving microneedle
mesoporous polydopamine nanoparticles
triamcinolone acetonide
oral ulcer
url https://www.frontiersin.org/articles/10.3389/fbioe.2023.1203709/full
work_keys_str_mv AT xiaoyingqu microneedlepatchescontainingmesoporouspolydopaminenanoparticlesloadedwithtriamcinoloneacetonideforthetreatmentoforalmucositis
AT xiaoliguo microneedlepatchescontainingmesoporouspolydopaminenanoparticlesloadedwithtriamcinoloneacetonideforthetreatmentoforalmucositis
AT tingtingzhu microneedlepatchescontainingmesoporouspolydopaminenanoparticlesloadedwithtriamcinoloneacetonideforthetreatmentoforalmucositis
AT zhezhang microneedlepatchescontainingmesoporouspolydopaminenanoparticlesloadedwithtriamcinoloneacetonideforthetreatmentoforalmucositis
AT wanchunwang microneedlepatchescontainingmesoporouspolydopaminenanoparticlesloadedwithtriamcinoloneacetonideforthetreatmentoforalmucositis
AT yuanpinghao microneedlepatchescontainingmesoporouspolydopaminenanoparticlesloadedwithtriamcinoloneacetonideforthetreatmentoforalmucositis